. Author manuscript; available in PMC: 2013 Nov 5.

Published in final edited form as: Open Urol Nephrol J. 2008;1:10.2174/1874303X00801010026. doi: 10.2174/1874303X00801010026

Table 2.

Paired Analysis for Advanced Cancer p Values

(Group Data from ref [3])	Test 1*	Test 2**
101 zinc group (10/36) vs nonuser group (317/2127)	0.06	0.06
101 zinc group (10/36) vs 1-24 zinc user group (56/469)	0.02	0.01
1-24 zinc group (56/469) vs nonuser group (317/2127)	0.11	0.11
*(no. adv cancer cases/total no. cases) Fisher exact test; Chi-square
101 zinc group (10/24) vs nonuser group (317/1540)	0.02	0.02
101 zinc group (10/24) vs 1-24 zinc user group (56/338)	0.005	0.005
1-24 zinc group (56/338) vs nonuser group (317/1540)	0.10	0.11
(no. adv cancer cases/sum of adv cases plus organ-confined cases)